Key facts
- This page summarizes Maxine Gowen's Form 4 filing for Aceragen, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 11 Aug 2023, 16:48.
Maxine Gowen - 10 Aug 2023 Form 4 Insider Report for Aceragen, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 10 Aug 2023
- Net transaction value
- -$26.01
- SEC form
- 4
- Accepted by SEC
- 11 Aug 2023, 16:48:06 UTC
- Prior SEC filing
- 12 Jun 2023
- Next SEC filing
- 09 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Maxine Gowen
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Maxine Gowen filed Form 4 for Aceragen, Inc. on 11 Aug 2023.
Change
- Previous filing in this sequence was filed on 12 Jun 2023.
- Current net transaction value: -$26.01.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ACGN
transaction
Common Stock
Sale
- Transaction value
- $26.01
- Shares
- -51
- Change %
- -100%
- Price
- $0.5100
- Shares after
- 0
- Date
- 10 Aug 2023
- Ownership
- By Trust
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Shares of common stock held in the name Brian Macdonald for Maxine Gowen Trust, for which the Reporting Person is a beneficiary and trustee.